MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control
May 29 - May 31, 2020
Presenter: Dr. John Sampson, MD, PhD, MHSc, MBA, Robert H. and Gloria Wilkins Distinguished Professor and Chair of Neurosurgery, Duke University School of Medicine
Abstract #: 2513
Session Title: CNS Tumors
Discussant: Dr. Ian Parney, MD, PhD
Abstract #: 2513
Session Title: CNS Tumors
Discussant: Dr. Ian Parney, MD, PhD
Supporting Materials
Download Presentation 9.3 MB